NanoViricides, Inc. (NNVC): A typical nanoviricides drug is designed like a chemical missile. It has a number of recognition "ligands" on its surface, that are specific to a single type of virus, say HIV. They are like the GPS on a directed missile. They will identify the enemy and attach to specific "landing sites" on the enemy target. The nanoviricides drug, after landing, spreads itself all over the virus particle, and thus completely neutralizes and disables the virus particle from binding to its target, a human cell.
Employees: 6
(Millions)
Market Cap: 192.76
Shares Outstanding: 161.99
Float: 117.86
Patents: Solubilization and Targeted Delivery of Drugs with Selfassembling Amphiphilic PolymersOral administration:
Antibody response with Oral administration was stronger than that with IV administration.
Internet Information
Home Page: nanoviricides.com
Investor Relations: nanoviricides.com
Corporate History/Profile: nanoviricides.com
Executives: nanoviricides.com
Products/Services: nanoviricides.com
Officers
Anil Diwan Chairman of the Board, President
Eugene Seymour Chief Executive Officer, Director
Meeta Vyas Interim Chief Financial Officer
Milton Boniuk Independent Director
Stanley Glick Independent Director
Mukund Kulkarni Independent Director
NanoViricides Inc Group Headquarters: SUITE 205, 135 WOOD STREET, WEST HAVEN, CT 06516, United States, |
